Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 2.16T | 2.10T | 2.18T | 1.90T | 1.90T | 1.48T |
Gross Profit | 677.45B | 603.02B | 584.52B | 563.85B | 563.85B | 434.32B |
EBITDA | 410.49B | 355.47B | 394.28B | 357.37B | 273.10B | 222.85B |
Net Income | 166.06B | 124.69B | 114.19B | 131.30B | 131.30B | 79.34B |
Balance Sheet | ||||||
Total Assets | 3.79T | 3.42T | 3.15T | 3.15T | 3.04T | 2.40T |
Cash, Cash Equivalents and Short-Term Investments | 818.37B | 650.00B | 558.33B | 558.33B | 506.28B | 446.33B |
Total Debt | 681.32B | 685.74B | 752.16B | 752.16B | 679.81B | 521.61B |
Total Liabilities | 1.88T | 1.70T | 1.68T | 1.68T | 1.74T | 1.40T |
Stockholders Equity | 1.89T | 1.71T | 1.46T | 1.46T | 1.30T | 1.00T |
Cash Flow | ||||||
Free Cash Flow | 258.30B | 228.42B | -12.94B | -12.94B | -112.35B | 10.46B |
Operating Cash Flow | 482.66B | 447.01B | 262.77B | 262.77B | 178.99B | 222.81B |
Investing Cash Flow | -224.24B | -216.59B | -234.40B | -234.40B | -281.55B | -231.49B |
Financing Cash Flow | -129.70B | -146.37B | 14.95B | 14.95B | 113.74B | 29.19B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $25.12B | 24.28 | 8.36% | 1.25% | 4.40% | -11.79% | |
80 Outperform | $6.39B | 25.66 | 11.58% | ― | 5.87% | 20.66% | |
79 Outperform | $4.64B | 51.88 | 5.89% | ― | 14.24% | 424.78% | |
74 Outperform | $20.14B | 23.57 | 17.67% | ― | -3.63% | 2.26% | |
72 Outperform | $18.70B | 67.12 | 5.06% | ― | -3.72% | -80.83% | |
67 Neutral | $22.32B | 39.50 | 32.41% | 0.15% | -6.13% | -53.35% | |
61 Neutral | $35.51B | 8.11 | -11.05% | 1.89% | 8.55% | -8.72% |